Development of a Critical Pathway for Patients with Uterine Artery Embolization / 여성건강간호학회지
Korean Journal of Women Health Nursing
;
: 316-325, 2006.
Article
Dans Coréen
| WPRIM
| ID: wpr-168050
ABSTRACT
PURPOSE:
The purpose of this study was to develop a Critical Pathway for Uterine Artery Embolization patients.METHOD:
There were 6 steps that were taken. Step 1 was selecting a diagnosis, and Step 2 was organizing a development team consisting of 7 experts. Step 3 analyzed the medical records, and Step 4 drew up a preliminary Critical Pathway. Step 5 tested the clinical validity of the preliminary Critical Pathway, and Step 6 developed the final Critical Pathway.RESULT:
The contents of the medical practices observed in the medical records were investigated in seven areas monitoring/assessment, treatment, medication, diet, activity, consults, and education/discharge plan; and a total of 73 items was identified. The validity of the 73 items was examined by a group of specialists. 68 items were adopted, 4 items revised, 1 item removed, and 1 item was added. Using the results, a preliminary Critical Pathway was drawn up. According to the results from examining the clinical validity of the preliminary Critical Pathway with five patients for five weeks, 3 items which showed discrepancy were revised and another 3 items were added. Then, the final Critical Pathway was completed.CONCLUSION:
This Critical Pathway needs to be clinically applied and continuously to measure its effects in terms of the length of stay, cost?effectiveness, and the patients' and staffs' satisfaction.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Spécialisation
/
Dossiers médicaux
/
Programme clinique
/
Diagnostic
/
Régime alimentaire
/
Embolisation d'artère utérine
/
Artère utérine
/
Durée du séjour
Type d'étude:
Etude diagnostique
/
Guide de pratique
/
Étude pronostique
Limites du sujet:
Humains
langue:
Coréen
Texte intégral:
Korean Journal of Women Health Nursing
Année:
2006
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS